Gene · 4102
Papers3,353
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 3,353
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Functional T Cell Reactivity to Melanocyte Antigens Is Lost during the Progression of Malignant Melanoma, but Is Restored by Immunization. | Cancers (Basel) | 2021 | 33435427 | PubTator, text mining | PubMed |
| Current Melanoma Treatments: Where Do We Stand? | Cancers (Basel) | 2021 | 33435389 | PubTator, text mining | PubMed |
| Deregulation of extracellular matrix modeling with molecular prognostic markers revealed by transcriptome sequencing and validations in Oral Tongue squamous cell carcinoma. | Sci Rep | 2021 | 33420101 | PubTator, text mining | PubMed |
| Computational Drug Repositioning Identifies Statins as Modifiers of Prognostic Genetic Expression Signatures and Metastatic Behavior in Melanoma. | J Invest Dermatol | 2021 | 33417917 | PubTator, text mining | PubMed |
| Long Non-Coding RNAs: Potential Biomarkers and Targets for Hepatocellular Carcinoma Therapy and Diagnosis. | Int J Biol Sci | 2021 | 33390845 | PubTator, text mining | PubMed |
| Personalized cancer vaccination in head and neck cancer. | Cancer Sci | 2021 | 33368875 | PubTator, text mining | PubMed |
| Dendritic cell vaccine therapy for colorectal cancer. | Pharmacol Res | 2021 | 33348026 | PubTator, text mining | PubMed |
| Re-examination of MAGE-A3 as a T-cell Therapeutic Target. | J Immunother | 2021 | 33284140 | PubTator, text mining | PubMed |
| The emerging role of immunotherapy for the treatment of sarcoma. | J Surg Oncol | 2021 | 33259653 | PubTator, text mining | PubMed |
| The discovery and development of oncolytic viruses: are they the future of cancer immunotherapy? | Expert Opin Drug Discov | 2021 | 33232188 | PubTator, text mining | PubMed |
| Considerations when treating high-grade pediatric glioma patients with immunotherapy. | Expert Rev Neurother | 2021 | 33225764 | PubTator, text mining | PubMed |
| Genomic profile and immune microenvironment in patients with relapsed stage IA lung adenocarcinoma. | Transl Oncol | 2021 | 33221686 | PubTator, text mining | PubMed |
| Dendritic cell vaccine immunotherapy; the beginning of the end of cancer and COVID-19. A hypothesis. | Med Hypotheses | 2021 | 33221134 | PubTator, text mining | PubMed |
| A balance score between immune stimulatory and suppressive microenvironments identifies mediators of tumour immunity and predicts pan-cancer survival. | Br J Cancer | 2021 | 33139798 | PubTator, text mining | PubMed |
| Microwave ablation enhances tumor-specific immune response in patients with hepatocellular carcinoma. | Cancer Immunol Immunother | 2021 | 33006650 | PubTator, text mining | PubMed |
| Combining therapeutic vaccines with chemo- and immunotherapies in the treatment of cancer. | Expert Opin Drug Discov | 2021 | 32867561 | PubTator, text mining | PubMed |
| The potential role of tumor-derived exosomes in diagnosis, prognosis, and response to therapy in cancer. | Expert Opin Biol Ther | 2021 | 32813990 | PubTator, text mining | PubMed |
| IGF2BP1 is the first positive marker for anaplastic thyroid carcinoma diagnosis. | Mod Pathol | 2021 | 32719445 | PubTator, text mining | PubMed |
| Cellular immunotherapies for cancer. | Ir J Med Sci | 2021 | 32607912 | PubTator, text mining | PubMed |
| Temozolomide: An Updated Overview of Resistance Mechanisms, Nanotechnology Advances and Clinical Applications. | Curr Neuropharmacol | 2021 | 32589560 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4102/papers?page=49